CRISPR /Cas‐mediated genome editing to treat EGFR ‐mutant lung cancer: a personalized molecular surgical therapy
Author:
Affiliation:
1. Department of Cardiothoracic Surgery Division of Thoracic Surgery Stanford University School of Medicine Stanford CA USA
2. VA Palo Alto Healthcare System Palo Alto CA USA
Publisher
EMBO
Subject
Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201506006
Reference10 articles.
1. American Cancer Society(2015)Cancer Facts and Figures 2015.Atlanta:American Cancer Society.
2. Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
3. Multiplex Genome Engineering Using CRISPR/Cas Systems
4. AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
5. Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Precision oncology revolution: CRISPR-Cas9 and PROTAC technologies unleashed;Frontiers in Genetics;2024-07-31
2. CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in lung cancer;Molecular Therapy;2024-07
3. CRISPR/Cas9 gene editing: a novel strategy for fighting drug resistance in respiratory disorders;Cell Communication and Signaling;2024-06-14
4. Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies;Vaccines;2024-06-07
5. Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer;Biomedicine & Pharmacotherapy;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3